pharma

Showing 15 posts of 2914 posts found.

reovirus_-_credit_nih

Common virus able to target brain cancer

January 4, 2018
Medical Communications, Research and Development biotech, brain cancer, drugs, pharma, pharmaceutical

Research emerging from the University of Leeds and The Institute of Cancer research has revealed that a virus, known as …

nice_new_london_office_internal_3_web

NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy

January 4, 2018
Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma

NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …

pfizer_chrome_plate

Pfizer makes $830m drug discovery pact with Arvinas

January 4, 2018
Research and Development, Sales and Marketing Arvinas, Pfizer, biotech, drugs, pharma, pharmaceutical

Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing …

artificial-intelligence-2228610_640

New AI system for lung cancer and heart disease could save NHS billions

January 4, 2018
Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma

A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …

allergan-westport-ireland_web

Allergan to axe over 1,000 positions in cost cutting measures

January 4, 2018
Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan was never far away from the headlines in 2017, particularly when it came to its second highest selling product, …

kress

Syntimmune brings in new CEO from Biogen

January 4, 2018
Syntimmune, biotech, drugs, pharma, pharmaceutical

Syntimmune has revealed that it has brought in a new CEO to begin the new year, with the appointment of …

eye-1173863_960_720

Spark’s bright idea on $850,000 blindness gene therapy

January 3, 2018
Sales and Marketing : Pharma, Spark Therapeutics, biotech, drugs, pharma, pharmaceutical

Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …

J&J’s predicted blockbuster depression posts P2 data

January 3, 2018
Research and Development Johnson & Johnson, biotech, depression, drugs, pharma, pharmaceutical

Johnson & Johnson has revealed Phase 2 data for its treatment for depression, esketamine, and the results are positive. The …

Novartis image

Novartis’ Kisqali gains breakthrough status in premenopausal breast cancer

January 3, 2018
Research and Development, Sales and Marketing Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received a major boost in its efforts to broaden use of its CDK4/6 inhibitor, by receiving a breakthrough …

mallinckrodt

Mallinckrodt bolsters business with $1.2bn buyout

January 3, 2018
Research and Development, Sales and Marketing Mallinckrodt, drugs, pharma, pharmaceutical, sucampo

Mallinckrodt has endured a tough 2017, with its share price falling by half over the course of the year. This …

Winter crisis hits, NHS hospitals cancel non-emergency operations

January 3, 2018
Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

There was ample warning that the NHS looked set to face another difficult winter season, the predictions now look to …

age

Diabetes drugs show potential in treating Alzheimer’s

January 3, 2018
Research and Development Alzheimer's disease, biotech, drugs, pharma, pharmaceutical

A group of researchers at Lancaster University have identified a drug currently used to treat type 2 diabetes that has …

epidiolex-100mg-carton-bottle-unenhanced-0074c-j10

GW Pharma applies to both EU and US for lead product

January 2, 2018
Manufacturing and Production, Sales and Marketing GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharmaceuticals had a busy festive period, after it announced that it had submitted to both the EU and the …

Pfizer headquarters

NICE to take another look at Pfizer’s leukaemia drug

January 2, 2018
Manufacturing and Production, Sales and Marketing NICE, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased. …

dermapace-product

FDA approves shock wave wound healing device

January 2, 2018
Manufacturing and Production, Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device …

The Gateway to Local Adoption Series

Latest content